Literature DB >> 19655434

East African countries struggle with visceral leishmaniasis.

Talha Burki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19655434     DOI： 10.1016/s0140-6736(09)61401-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Molecular Diagnosis of Visceral Leishmaniasis.

Authors:  Shyam Sundar; Om Prakash Singh
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

2.  Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Authors:  Endalamaw Gadisa; Estefanía Custodio; Carmen Cañavate; Luis Sordo; Zelalem Abebe; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Lawrence Yamuah; Howard Engers; Javier Moreno; Israel Cruz
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

3.  Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia.

Authors:  Michael O Harhay; Piero L Olliaro; Michel Vaillant; François Chappuis; María Angeles Lima; Koert Ritmeijer; Carlos Henrique Costa; Dorcas Lamounier Costa; Suman Rijal; Shyam Sundar; Manica Balasegaram
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

Review 4.  Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.

Authors:  Temmy Sunyoto; Julien Potet; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-09

5.  Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia.

Authors:  Getachew Alebie; Amha Worku; Siele Yohannes; Befikadu Urga; Asrat Hailu; Dagimawie Tadesse
Journal:  Parasit Vectors       Date:  2019-05-06       Impact factor: 3.876

Review 6.  Nanodiagnostics in leishmaniasis: A new frontiers for early elimination.

Authors:  Mallikarjuna Rao Gedda; Prasoon Madhukar; Ashish Shukla; Shyam Lal Mudavath; Onkar Nath Srivastava; Om Prakash Singh; Shyam Sundar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-03

7.  Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Ayman B Y M Nour; Pètra F Mens; Al-Badawi A Talha; Emily R Adams; Hashim B M Ahmed; Samira H Abdelrahman; Koert Ritmeijer; Bakri Y M Nour; Henk D F H Schallig
Journal:  BMC Public Health       Date:  2013-04-11       Impact factor: 3.295

Review 8.  Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  J Parasitol Res       Date:  2015-12-30

Review 9.  A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

Authors:  Waleed Al-Salem; Jennifer R Herricks; Peter J Hotez
Journal:  Parasit Vectors       Date:  2016-08-22       Impact factor: 3.876

10.  "Kala-Azar is a Dishonest Disease": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan.

Authors:  Temmy Sunyoto; Gamal K Adam; Atia M Atia; Yassin Hamid; Rabie Ali Babiker; Nugdalla Abdelrahman; Catiane Vander Kelen; Koert Ritmeijer; Gabriel Alcoba; Margriet den Boer; Albert Picado; Marleen Boelaert
Journal:  Am J Trop Med Hyg       Date:  2018-02-22       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.